Cargando…

PD-L1 protein expression by Combined Positive Score (CPS) in patients with muscle invasive or advanced urothelial carcinoma: a single institution experience

INTRODUCTION: Immune checkpoint inhibitors have revolutionized the treatment of patients with advanced urothelial carcinoma (UC) in the frontline and relapsed settings. Lebanon has one of the highest incidence of UC worldwide, yet no data exists regarding the expression of PD-L1 by Combined Positive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasr, Sarah, Haddad, Fadi G., Khazen, Joseph, Kattan, Joseph, Trak-Smayra, Viviane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474619/ https://www.ncbi.nlm.nih.gov/pubmed/37658290 http://dx.doi.org/10.1186/s12885-023-11299-y

Ejemplares similares

Molecular characteristics of colorectal cancer in a Middle Eastern population in a single institution
por: Ibrahim, Tony, et al.
Publicado: (2018)

A 58-Year-Old Woman with Acute Gastric Perforation Due to Metastatic Ductal Carcinoma 18 Years Following Bilateral Mastectomy for Invasive Ductal Carcinoma of the Breast
por: Nehmeh, William A., et al.
Publicado: (2021)

Osteitis fibrosa cystica mimicking bone tumor, a case report
por: Nasser, Maya L., et al.
Publicado: (2021)

A Case Report Presenting an Undifferentiated Pancreatic Carcinoma with Osteoclastic-Like Giant Cells with an Unusual Indolent Course
por: Nehmeh, William A., et al.
Publicado: (2019)

Characteristics of nonalcoholic fatty liver disease induced in wistar rats following four different diets
por: Fakhoury-Sayegh, Nicole, et al.
Publicado: (2015)

Sequential Therapy with Gemcitabine and Carboplatin Followed by Paclitaxel as First Line Treatment for Advanced Urothelial Cancer
por: Kattan, Joseph G, et al.
Publicado: (2012)

Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate
por: Witte, Hanno M., et al.
Publicado: (2020)

Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey
por: Moujaess, Elissar, et al.
Publicado: (2021)

PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype
por: Kim, Bohyun, et al.
Publicado: (2020)

Interpretation According to Clone-Specific PD-L1 Cutoffs Reveals Better Concordance in Muscle-Invasive Urothelial Carcinoma
por: Huang, Tzu-Hao, et al.
Publicado: (2021)

Role of immunotherapy in localized muscle invasive urothelial cancer
por: Kaur, Jasmeet, et al.
Publicado: (2021)

PD-1 inhibitor toripalimab with gemcitabine as a neoadjuvant therapy for muscle-invasive bladder urothelial carcinoma: A case report
por: Yin, Huaqi, et al.
Publicado: (2022)

High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma
por: Széles, Ádám, et al.
Publicado: (2022)

Corrigendum: Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
por: Sayegh, Souraya, et al.
Publicado: (2019)

Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
por: Sayegh, Souraya, et al.
Publicado: (2019)

Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
por: Sanford, Thomas, et al.
Publicado: (2018)

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
por: Frydenlund, Noah, et al.
Publicado: (2018)

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
por: Xylinas, E, et al.
Publicado: (2013)

Protective Effect of Nasal Colonisation with ∆cps/piaA and ∆cps/proABC Streptococcus pneumoniae Strains against Recolonisation and Invasive Infection
por: Ramos-Sevillano, Elisa, et al.
Publicado: (2021)

Novel and emerging approaches in the management of non-muscle invasive urothelial carcinoma
por: Yassaie, Omid, et al.
Publicado: (2021)

Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs
por: Maeda, Shingo, et al.
Publicado: (2022)

Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers
por: Hoggarth, Zachary E., et al.
Publicado: (2018)

The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience
por: Kattan, Clarisse, et al.
Publicado: (2020)

The CPS improvement programme
por: Standley, P H
Publicado: (1965)

The CPS improvement programme
por: Standley, P H
Publicado: (1965)

The CPS target system
por: Reich, K H
Publicado: (1961)

CPS user's handbook
por: CERN. Geneva. Proton Synchrotron Division
Publicado: (1961)

Preparations for deuterons in the CPS
por: Asboe-Hansen, P
Publicado: (1976)

Accelerator development of the CPS
por: Baconnier, Y
Publicado: (1982)

Bellini Duct Carcinoma Misdiagnosed with Urothelial Papillary Carcinoma
por: El Khoury, Joey, et al.
Publicado: (2020)

PSB-CPS MD 22.05.97: matching between PSB and CPS
por: Benedikt, M, et al.
Publicado: (1997)

Improvement programme for the CPS controls: The Working Party of CPS Controls (see acknowledgements)
por: Asseo, E
Publicado: (1976)

A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon
por: Temraz, Sally, et al.
Publicado: (2022)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma
por: Basatac, Cem, et al.
Publicado: (2019)

Bioinformatic Identification of Potential Hub Genes in Muscle-Invasive Bladder Urothelial Carcinoma
por: Guo, Changgang, et al.
Publicado: (2020)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Muscle invasive urinary bladder urothelial carcinoma presenting with secondary nephrotic symptoms
por: Mizusawa, Hiroya, et al.
Publicado: (2021)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ht64l68us6ejvbdft7p5po3toe